Solid Biosciences
SLDB
SLDB
66 hedge funds and large institutions have $79.1M invested in Solid Biosciences in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
0% more call options, than puts
Call options by funds: $182K | Put options by funds: $182K
7% less funds holding
Funds holding: 71 → 66 (-5)
31% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 16
Holders
66
Holding in Top 10
1
Calls
$182K
Puts
$182K
Top Buyers
| 1 | +$19.8M | |
| 2 | +$1.19M | |
| 3 | +$1.15M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$729K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$244K |
Top Sellers
| 1 | -$722K | |
| 2 | -$569K | |
| 3 | -$345K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$239K |
| 5 |
SIM
Spark Investment Management
New York
|
-$188K |